newsfilter
← Latest News
PR Newswire·

Mirati Therapeutics Announces Departure of Chief Financial Officer Laurie Stelzer

SAN DIEGO, Aug. 23, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ:MRTX), a commercial stage biotechnology company, today announced that Laurie Stelzer, Chief Financial Officer, will depart the company on